Shares in Bayer rose on Monday after the U.S. Supreme Court said it would take an appeal from the German conglomerate, ...

President Donald Trump's administration in December urged the Supreme Court to take up Bayer's appeal. In a brief filed at ...

Bayer AG’s shares surged after the US Supreme Court said it would hear the company’s appeal in a Roundup case that could ...

The Supreme Court on Friday announced it will review Bayer’s petition to decide whether the federal Insecticide, Fungicide, and Rodenticide Act preempts a label-based failure-to-warn claim where EPA ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court ​on Tuesday for ...

High court gives company hope in its effort to mitigate long-running litigation that has cost it billions of dollars.

Secondary US filings for Bayer assets cannot be relied on again to face future patent cliffs, demanding focus on early-stage ...

Bayer A.G. stock: contrarian Buy with €35 target. Click for this updated look at BAYZF stock prospects and why I am neutral ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage ...

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.